Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408115 · ClinicalTrials.gov registry record · NA
Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women
A NA study of Hot Flashes and Vasomotor Symptoms, sponsored by Bonafide Health.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT07408115 is a NA study of Hot Flashes and Vasomotor Symptoms that has completed, run by Bonafide Health. The registered enrollment target is 112 participants, below the 167-participant average among 23 other Hot Flashes trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07408115, a NA study of Hot Flashes and Vasomotor Symptoms, has completed, sponsored by Bonafide Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the efficacy of a neurokinin 1,3 antagonist on improving vasomotor symptoms (VMS) and overall menopause symptoms in women between the ages of 40-70. The primary research question is whether taking the study product daily for 4 weeks with an optional 8 week extension, significantly reduces the severity and frequency of menopause-related symptoms.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT JDS-HF3.0
Study Locations (1)
New York
- Bonafide Health - Harrison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2024-05-24 |
| Est. Completion | 2024-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07408115
The ClinicalTrials.gov registry entry for NCT07408115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 23 other Hot Flashes trials with a reported enrollment target (33% lower). The listed sponsor is Bonafide Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Hot Flashes appearing as the primary indexed condition, and to 1 intervention - of which JDS-HF3.0 is the first listed.
NCT07408115 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07408115 about?
NCT07408115 is a clinical study titled "Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women". The goal of this study is to evaluate the efficacy of a neurokinin 1,3 antagonist on improving vasomotor symptoms (VMS) and overall menopause symptoms in women between the ages of 40-70. The primary research question is whether taking the study product daily for 4 weeks with an optional 8 week exten...
What is the current status of trial NCT07408115?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2024-05-24. Estimated completion is 2024-12-18.
What conditions does trial NCT07408115 study?
This clinical trial studies the following conditions: Hot Flashes, Vasomotor Symptoms, Night Sweats, Hot Flushes, Hot Flash.
What interventions are being tested in trial NCT07408115?
The interventions under investigation include: JDS-HF3.0 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07408115?
This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07408115 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hot Flashes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
RECRUITING · NA
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.